{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:28Z","timestamp":1761058768706,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1124\/jpet.107.132357","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T02:23:46Z","timestamp":1202955826000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03b1-Aminoazaheterocyclic-Methylglyoxal Adducts Do Not Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Activity"],"prefix":"10.1016","volume":"325","author":[{"given":"N.D.","family":"Sonawane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Zegarra-Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Namkung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.V.","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.132357_bib1","doi-asserted-by":"crossref","unstructured":"Benton DC, Monaghan AS, Hosseini R, Bahia PK, Haylett DG, and Moss GW (2003) Small conductance Ca 2+-activated K+ channels formed by the expression of rat SK1 and SK2 genes in HEK 293 cells. J Physiol 553: 13\u201319.","DOI":"10.1113\/jphysiol.2003.054551"},{"key":"10.1124\/jpet.107.132357_bib2","doi-asserted-by":"crossref","unstructured":"Bkaily G, Sperelakis N, Renaud JF, and Payet MD (1985) Apamin, a highly specific Ca2+ blocking agent in heart muscle. Am J Physiol Heart Circ Physiol 248: H961\u2013H965.","DOI":"10.1152\/ajpheart.1985.248.6.H961"},{"key":"10.1124\/jpet.107.132357_bib3","doi-asserted-by":"crossref","unstructured":"Castle NA, London DO, Creech C, Fajloun Z, Stocker JW, and Sabatier JM (2003) Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channels. Mol Pharmacol 63: 409\u2013418.","DOI":"10.1124\/mol.63.2.409"},{"key":"10.1124\/jpet.107.132357_bib4","doi-asserted-by":"crossref","unstructured":"Favreau P, Gilles N, Lamthanh H, Bournaud R, Shimahara T, Bouet F, Laboute P, Letourneux Y, Menez A, Molgo J, et al. (2001) A new omega-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity. Biochemistry 40: 14567\u201314575.","DOI":"10.1021\/bi002871r"},{"key":"10.1124\/jpet.107.132357_bib5","doi-asserted-by":"crossref","unstructured":"Galietta LJ, Folli C, Marchetti C, Romano L, Carpani D, Conese M, and Zegarra-Moran O (2000) Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. Am J Physiol Lung Cell Mol Physiol 278: L1186\u2013L1194.","DOI":"10.1152\/ajplung.2000.278.6.L1186"},{"key":"10.1124\/jpet.107.132357_bib6","doi-asserted-by":"crossref","unstructured":"Galietta LJ, Springsteel MF, Eda M, Niedzinski EJ, By K, Haddadin MJ, Kurth MJ, Nantz MH, and Verkman AS (2001) Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquino-benlizinium lead compounds. J Biol Chem 276: 19723\u201319728.","DOI":"10.1074\/jbc.M101892200"},{"key":"10.1124\/jpet.107.132357_bib7","doi-asserted-by":"crossref","unstructured":"Grunnet M, Jensen BS, Olesen SP, and Klaerke DA (2001) Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch 441: 544\u2013550.","DOI":"10.1007\/s004240000447"},{"key":"10.1124\/jpet.107.132357_bib8","doi-asserted-by":"crossref","unstructured":"Li H, Findlay IA, and Sheppard DN (2004) The relationship between cell proliferation, Cl\u2013 secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int 66: 1926\u20131938.","DOI":"10.1111\/j.1523-1755.2004.00967.x"},{"key":"10.1124\/jpet.107.132357_bib9","doi-asserted-by":"crossref","unstructured":"Ma T, Vetrivel L, Yang H, Pedemonte N, Zegarra-Moran N, Galietta LJV, and Verkman AS (2002a) High-affinity activators of CFTR chloride conductance identified by high-throughput screening. J Biol Chem 277: 37235\u201337241.","DOI":"10.1074\/jbc.M205932200"},{"key":"10.1124\/jpet.107.132357_bib10","doi-asserted-by":"crossref","unstructured":"Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, and Verkman AS (2002b) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651\u20131658.","DOI":"10.1172\/JCI0216112"},{"key":"10.1124\/jpet.107.132357_bib11","doi-asserted-by":"crossref","unstructured":"Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, and Verkman AS (2004) Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125\u2013137.","DOI":"10.1085\/jgp.200409059"},{"key":"10.1124\/jpet.107.132357_bib12","doi-asserted-by":"crossref","unstructured":"Routaboul C, Dumas L, Vergne J, Gautier-Luneau I, Maurel M-C, and D\u00e9cout J-L (2002) New stereoselective reaction of methylglyoxal with 2-aminopyridine and adenine derivatives: formation of imino acid-nucleic base derivatives in water under mild conditions. Chem Commun 10: 1114\u20131115.","DOI":"10.1039\/b201901a"},{"key":"10.1124\/jpet.107.132357_bib13","doi-asserted-by":"crossref","unstructured":"Routaboul C, Norez C, Melin P, Molina MC, Boucherle B, Bossard F, Noel S, Robert R, Gauthier C, Becq F, et al. (2007) Discovery of \u03b1-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels. J Pharmacol Exp Ther 322: 1023\u20131035.","DOI":"10.1124\/jpet.107.123307"},{"key":"10.1124\/jpet.107.132357_bib14","doi-asserted-by":"crossref","unstructured":"Sheppard DN and Welsh MJ (1999) Structure and function of the CFTR chloride channel. Physiol Rev 79: S23\u2013S45.","DOI":"10.1152\/physrev.1999.79.1.S23"},{"key":"10.1124\/jpet.107.132357_bib15","doi-asserted-by":"crossref","unstructured":"Sonawane ND, Hu J, Muanprasat C, and Verkman AS (2006) Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid losses in cholera. FASEB J 20: 130\u2013132.","DOI":"10.1096\/fj.05-4818fje"},{"key":"10.1124\/jpet.107.132357_bib16","doi-asserted-by":"crossref","unstructured":"Sonawane ND, Zhao D, Zegarra-Mora O, Galietta LJV, and Verkman AS (2007) Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera. Gastroenterology 132: 1234\u20131244.","DOI":"10.1053\/j.gastro.2007.02.018"},{"key":"10.1124\/jpet.107.132357_bib17","doi-asserted-by":"crossref","unstructured":"Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, and Galietta LJ (2004) Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 558: 52\u201356.","DOI":"10.1016\/S0014-5793(04)00011-0"},{"key":"10.1124\/jpet.107.132357_bib18","doi-asserted-by":"crossref","unstructured":"Thiagarajah J, Broadbent T, Hsieh E, and Verkman AS (2004) Prevention of toxininduced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126: 511\u2013519.","DOI":"10.1053\/j.gastro.2003.11.005"},{"key":"10.1124\/jpet.107.132357_bib19","doi-asserted-by":"crossref","unstructured":"Thiagarajah JR and Verkman AS (2005) New drug targets for cholera therapy. Trends Pharmacol Sci 26: 172\u2013175.","DOI":"10.1016\/j.tips.2005.02.003"},{"key":"10.1124\/jpet.107.132357_bib20","doi-asserted-by":"crossref","unstructured":"Verkman AS, Lukacs GL, and Galietta LJ (2006) CFTR chloride channel drug discovery\u2014inhibitors as antidiarrheals and activators for therapy of cystic fibrosis. Curr Pharm Des 12: 2235\u20132247.","DOI":"10.2174\/138161206777585148"},{"key":"10.1124\/jpet.107.132357_bib21","doi-asserted-by":"crossref","unstructured":"Yang B, Sonawane ND, Zhao D, Somlo S, and Verkman AS (2008) Small-molecule CFTR inhibitors slow cyst growth in culture and mouse models of polycystic kidney disease. J Am Soc Nephrol, in press.","DOI":"10.1096\/fasebj.22.1_supplement.942.3"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.132357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:36:51Z","timestamp":1740004611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524344167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0022356524344167"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.132357","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Aminoazaheterocyclic-Methylglyoxal Adducts Do Not Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.132357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}